The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats
Open accessAbstract
The hypothesis tested in the present study is that dietary fructans are able to modulate gastrointestinal peptides involved in the control of food intake, namely glucagon-like peptide (GLP)-1 (7-36) amide and ghrelin. After 3 weeks of treatment with a standard diet (control) or the same diet enriched with 100 g fructans varying in their degrees of polymerization (oligofructose (OFS), Synergy 1 (Syn) or long chain inulin)/kg, male Wistar rats were deprived of food for 8 h before sample collection. Dietary energy intake throughout the experiment was significantly lower (P>0·05) in fructans-fed rats than in control rats, leading to a significant decrease (P>0·01) in epidydimal fat mass at the end of the treatment in OFS- and Syn-treated rats. GLP-1 (7-36) amide concentration in portal vein serum was higher in OFS- and Syn-fed than in control rats. Both GLP-1 (7-36) amide concentration and proglucagon mRNA concentrations were significantly greater (P>0·05) in the proximal colonic mucosa of fructans-fed rats v.controls. Normally active ghrelin concentration in plasma increases during food deprivation and rapidly falls during a meal. In the present study, after 8 h of food deprivation, active ghrelin in the plasma remained significantly lower (P>0·05) in OFS and Syn-fed than in control rats. These results are in accordance with the modifications of dietary intake and fat-mass development in short-chain fructans-treated rats and demonstrate the potential modulation of GLP-1 (7-36) amide and ghrelin by fermentable fibres such as fructans, which are rapidly and extensively fermented in the proximal part of the colon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Cowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402 · cited 1×
“There are several papers showing that peripheral injection of GLP-1 (7-36) amide decreases food intake and consequently body weight in rats and human subjects (Flint et al. 1998; Naslund et al. 1999; Meier et al. 2002; Zander et al. 2002).”
BackgroundZander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297 · cited 1×
“There are several papers showing that peripheral injection of GLP-1 (7-36) amide decreases food intake and consequently body weight in rats and human subjects (Flint et al. 1998; Naslund et al. 1999; Meier et al. 2002; Zander et al. 2002).”
BackgroundTechnological functionality of inulin and oligofructose
A.*, F. (2002) · British Journal of Nutrition · doi:10.1079/bjnbjn/2002550 · Cited by 475
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J., Holst, J., Rössner, S., & Hellström, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800818 · Cited by 468 · cited 1×
“There are several papers showing that peripheral injection of GLP-1 (7-36) amide decreases food intake and consequently body weight in rats and human subjects (Flint et al. 1998; Naslund et al. 1999; Meier et al. 2002; Zander et al. 2002).”
BackgroundRole of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion
Rocca, A. S., & Brubaker, P. L. (1999) · Endocrinology · doi:10.1210/en.140.4.1687 · Cited by 464
Preitner, F., Ibberson, M., Franklin, I., Binnert, C., Pende, M., Gjinovci, A., Hansotia, T., Drucker, D. J., Wollheim, C., Burcelin, R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420518 · Cited by 256
Research works printed but not linked: 6
- Van Loo, 1999, Functional food properties of non-digestible oligosaccharides – Reply, Br J Nutr, 82, 32, 10.1017/S0007114599001531 · doi:10.1017/s0007114599001531
- 10.1210/endo.140.4.6643 · doi:10.1210/endo.140.4.6643 · Paper page
- 10.1210/endo.137.9.8756571 · doi:10.1210/endo.137.9.8756571 · Paper page
- 10.1128/MCB.7.1.560 · DOI
- 2000, American Diabetes Association, Diabetes Care, 23, S43
- 10.1079/BJN/2002550 · doi:10.1079/bjn/2002550
Cited by
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Self-citationGut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Self-citationShort-chain fatty acids in control of body weight and insulin sensitivity
Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298
Prebiotic effects: metabolic and health benefits
Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,085
Self-citationThe short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4611 · Cited by 1,771
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,774
Self-citationInsulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076
Self-citationNext-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
Self-citationProbiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2008_097 · Cited by 1,028
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974
Self-citationBile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“The gut microbiota affected the release of gut hormones, such as peptide YY and GLP1 (Reimer and McBurney, 1996; Kok et al., 1998; Cani et al., 2004), and low-grade inflammation (Noverr and Huffnagle, 2004; Cani et al.”
BackgroundPsichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., Ghatei, M. A., Bloom, S. R., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.153 · Cited by 886
Cani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864
Self-citationThe Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
Targeting gut microbiota in obesity: effects of prebiotics and probiotics
Delzenne, N. M., Neyrinck, A. M., Bäckhed, F., & Cani, P. D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.126 · Cited by 779
Self-citationCani, P. D., Lecourt, E., Dewulf, E. M., Sohet, F. M., Pachikian, B. D., Naslain, D., De Backer, F., Neyrinck, A. M., & Delzenne, N. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28095 · Cited by 762
Self-citationIntestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
“Insulin (pmol/L) 21 (15-61) 33 (15-465) 97 (29-437)”
InfluentialParnell, J. A., & Reimer, R. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27465 · Cited by 729
The role of short chain fatty acids in appetite regulation and energy homeostasis
Byrne, C. S., Chambers, E. S., Morrison, D. J., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.84 · Cited by 707
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
González Hernández, M. A., Canfora, E. E., Jocken, J. W. E., & Blaak, E. E. (2019) · Nutrients · doi:10.3390/nu11081943 · Cited by 624
Gut Microbiota and Its Possible Relationship With Obesity
DiBaise, J. K., Zhang, H., Crowell, M. D., Krajmalnik-Brown, R., Decker, G. A., & Rittmann, B. E. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.460 · Cited by 605
The gut microbiota, obesity and insulin resistance
Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599
Anxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573
Microbial regulation of organismal energy homeostasis
Cani, P. D., Van Hul, M., Lefort, C., Depommier, C., Rastelli, M., & Everard, A. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0017-4 · Cited by 569
Self-citationDiabetes, obesity and gut microbiota
Everard, A., & Cani, P. D. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.007 · Cited by 543
Self-citationBeta Glucan: Health Benefits in Obesity and Metabolic Syndrome
El Khoury, D., Cuda, C., Luhovyy, B. L., & Anderson, G. H. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/851362 · Cited by 538
An overview of the last advances in probiotic and prebiotic field
Saad, N., Delattre, C., Urdaci, M., Schmitter, J. M., & Bressollier, P. (2013) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2012.05.014 · Cited by 522
Gérard, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2061-5 · Cited by 508
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482
Effects of dietary fibers on disturbances clustered in the metabolic syndrome
Galisteo, M., Duarte, J., & Zarzuelo, A. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.02.009 · Cited by 477
Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M., McCutcheon, K. L., Shen, L., Danna, S. C., Tripathy, S., Hegsted, M., & Keenan, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90637.2008 · Cited by 460
The role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457
Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health
Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa181 · Cited by 451
Interaction Between Obesity and the Gut Microbiota: Relevance in Nutrition
Delzenne, N. M., & Cani, P. D. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145146 · Cited by 411
Self-citationGut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
Cani, P. D., & Jordan, B. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0025-6 · Cited by 383
Self-citationOligofructose Promotes Satiety in Rats Fed a High‐Fat Diet: Involvement of Glucagon‐Like Peptide‐1
Cani, P. D., Neyrinck, A. M., Maton, N., & Delzenne, N. M. (2005) · Obesity Research · doi:10.1038/oby.2005.117 · Cited by 382
Self-citationOligofructose promotes satiety in healthy human: a pilot study
Cani, P. D., Joly, E., Horsmans, Y., & Delzenne, N. M. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602350 · Cited by 382
Self-citationDahiya, D. K., Renuka, Puniya, M., Shandilya, U. K., Dhewa, T., Kumar, N., Kumar, S., Puniya, A. K., & Shukla, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00563 · Cited by 352
The gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 350
Self-citationControl of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
Chambers, E. S., Morrison, D. J., & Frost, G. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001657 · Cited by 342
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
He, M., & Shi, B. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0183-1 · Cited by 336
Role of Leptin in Inflammation and Vice Versa
Pérez-Pérez, A., Sánchez-Jiménez, F., Vilariño-García, T., & Sánchez-Margalet, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165887 · Cited by 330
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders
Yoo, J., & Kim, S. (2016) · Nutrients · doi:10.3390/nu8030173 · Cited by 328
The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective
Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.04.002 · Cited by 326
“Similarly, food intake, body weight and fat mass were all decreased in male Wistar rats after administration of three different prebiotics (Cani et al., 2004).”
BackgroundHow gut microbes talk to organs: The role of endocrine and nervous routes
Cani, P. D., & Knauf, C. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.011 · Cited by 321
Self-citationThe gut microbiota in obesity and weight management: microbes as friends or foe?
Van Hul, M., & Cani, P. D. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00794-0 · Cited by 318
Self-citationImpact of inulin and oligofructose on gastrointestinal peptides
Delzenne, N. M., Cani, P. D., Daubioul, C., & Neyrinck, A. M. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041342 · Cited by 313
Self-citationDiamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308
The Gut Microbiome Influences Host Endocrine Functions
Rastelli, M., Cani, P. D., & Knauf, C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00280 · Cited by 307
Self-citationSherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 295
Parnell, J. A., & Reimer, R. A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511003163 · Cited by 294
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats
Cani, P. D., Hoste, S., Guiot, Y., & Delzenne, N. M. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507691648 · Cited by 274
Self-citationRole of the gut-brain axis in energy and glucose metabolism
Wachsmuth, H. R., Weninger, S. N., & Duca, F. A. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00677-w · Cited by 269
Bile acids as metabolic regulators
Li, T., & Chiang, J. Y. L. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000156 · Cited by 269
Metabolic activities and probiotic potential of bifidobacteria
Russell, D. A., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.06.003 · Cited by 267
Bauer, P. V., Duca, F. A., Waise, T. M. Z., Rasmussen, B. A., Abraham, M. A., Dranse, H. J., Puri, A., O’Brien, C. A., & Lam, T. K. T. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.019 · Cited by 265
Cani, P. D., Delzenne, N. M., Amar, J., & Burcelin, R. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2007.09.008 · Cited by 263
Self-citationWorthington, J. J., Reimann, F., & Gribble, F. M. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.73 · Cited by 262
Gut microorganisms as promising targets for the management of type 2 diabetes
Delzenne, N. M., Cani, P. D., Everard, A., Neyrinck, A. M., & Bindels, L. B. (2015) · Diabetologia · doi:10.1007/s00125-015-3712-7 · Cited by 262
Self-citationEverard, A., & Cani, P. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9288-6 · Cited by 261
Self-citationCani, P. D., Daubioul, C. A., Reusens, B., Remacle, C., Catillon, G., & Delzenne, N. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06100 · Cited by 197
Self-citationShort-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling
Torres‐Fuentes, C., Golubeva, A. V., Zhdanov, A. V., Wallace, S., Arboleya, S., Papkovsky, D. B., Aidy, S. E., Ross, P., Roy, B. L., Stanton, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901433r · Cited by 154
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Going with the grain: Fiber, cognition, and the microbiota-gut-brain-axis
Berding, K., Carbia, C., & Cryan, J. F. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221995785 · Cited by 100
Do SCFA have a role in appetite regulation?
Darzi, J., Frost, G. S., & Robertson, M. D. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110004039 · Cited by 94
“Supplementing rats diets with Synergy 1 (mixture of low- and high-DP inulin-type fructans) resulted in significantly suppressed BW gain((52)) and fat mass gain((50)), reduced EI((50,52)), reduced proximal colon GLP-1 (7–36) concentrations((50)) and reduced caecum mass((50)).”
BackgroundMethodBarrea, L., Muscogiuri, G., Annunziata, G., Laudisio, D., Pugliese, G., Salzano, C., Colao, A., & Savastano, S. (2019) · Hormones · doi:10.1007/s42000-019-00100-0 · Cited by 81
Cluny, N. L., Eller, L. K., Keenan, C. M., Reimer, R. A., & Sharkey, K. A. (2015) · Obesity · doi:10.1002/oby.21017 · Cited by 72
Antibiotic administration and the development of obesity in children
Principi, N., & Esposito, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.12.017 · Cited by 70
Incretin Hormones, Obesity and Gut Microbiota
Angelini, G., Russo, S., & Mingrone, G. (2024) · Peptides · doi:10.1016/j.peptides.2024.171216 · Cited by 47
Dagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
Enteroendocrine Cells: Metabolic Relays between Microbes and Their Host
Plovier, H., & Cani, P. D. (2017) · Endocrine Development · doi:10.1159/000475736 · Cited by 36
Self-citation
Metadata
- Authors
- Cani, P. D., Dewever, C., & Delzenne, N. M.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-09
- Volume
- 92
- Issue
- 3
- Pages
- 521-526
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2027752015
- Cited by
- 447
- References
- 32
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.